The goal is to attract scientists with expertise in patient care, pathology, translational research, epigenomics, molecular biology, bioinformatics, drug development, aiming to reduce fragmentation in clinical management and translational research in ovarian cancer.

The meeting has been accredited with 10 ESMO-MORA cat 1 points.